Precigen Inc (PGEN)
1.42
+0.02
(+1.43%)
USD |
NASDAQ |
Apr 24, 16:00
1.425
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -14.58M |
| March 31, 2023 | 44.17M |
| December 31, 2022 | -39.28M |
| September 30, 2022 | -115.73M |
| June 30, 2022 | -0.113M |
| March 31, 2022 | -0.163M |
| December 31, 2021 | -0.11M |
| September 30, 2021 | 0.234M |
| June 30, 2021 | 0.023M |
| March 31, 2021 | 121.04M |
| December 31, 2020 | -0.072M |
| September 30, 2020 | -0.114M |
| June 30, 2020 | -1.26M |
| March 31, 2020 | 34.15M |
| December 31, 2019 | 25.77M |
| September 30, 2019 | 0.045M |
| June 30, 2019 | -0.033M |
| March 31, 2019 | 6.927M |
| December 31, 2018 | 27.25M |
| September 30, 2018 | 193.60M |
| June 30, 2018 | 0.684M |
| March 31, 2018 | 88.26M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.70M |
| September 30, 2017 | -6.682M |
| June 30, 2017 | 0.408M |
| March 31, 2017 | -3.146M |
| December 31, 2016 | 0.903M |
| September 30, 2016 | -5.724M |
| June 30, 2016 | 7.294M |
| March 31, 2016 | 9.592M |
| December 31, 2015 | 0.242M |
| September 30, 2015 | 213.05M |
| June 30, 2015 | 7.73M |
| March 31, 2015 | 110.66M |
| December 31, 2014 | 1.409M |
| September 30, 2014 | -3.376M |
| June 30, 2014 | 0.757M |
| March 31, 2014 | 25.21M |
| December 31, 2013 | 0.472M |
| September 30, 2013 | 169.00M |
| June 30, 2013 | 83.91M |
| March 31, 2013 | 63.07M |
| December 31, 2012 | 25.20M |
| September 30, 2012 | 0.199M |
| June 30, 2012 | 8.345M |
| March 31, 2012 | 42.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-115.73M
Minimum
Sep 2022
121.04M
Maximum
Mar 2021
2.840M
Average
-0.033M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.999M |
| HealthEquity Inc | 4.115M |
| Corvus Pharmaceuticals Inc | 0.00 |
| Oragenics Inc | -0.1806M |
| MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.77M |
| Cash from Investing (Quarterly) | 13.29M |
| Free Cash Flow | -68.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0675 |
| Free Cash Flow to Equity (Quarterly) | -16.81M |
| Free Cash Flow to Firm (Quarterly) | -16.81M |
| Free Cash Flow Yield | -19.71% |